Ruthenium (IV) oxyde hydrat CAS NO.32740-79-7
| Amakuru y'ibicuruzwa | |||
| Izina | Ruthenium (IV) oxyde hydrat | ||
| URUBANZA OYA. | 32740-79-7 | ||
| Inzira ya molekulari | RuO2.2H2O | Uburemere bwa molekile | 151.08 |
| MDL No. | MFCD00149846 | EINECS | 629-041-8 |
| Depite | 1200 (subl.) | BP | NA |
| Ubucucike | NA | Ironderero | NA |
| FP | NA | Imiterere y'ububiko | Ikirere cyuzuye, Ubushyuhe bwo mucyumba |
| Kugaragara | Ifu yumukara | ||
| Isuku | 99% | ||
| Gusaba | 1. Anhydrous ruthenium oxyde ni cataliste yimiti nibikoresho byingenzi byo gukora résistorants na capacator. 2. Hydrogen ruthenium dioxyde (RuO2.xH2O) ifite ubushobozi bwihariye cyane hamwe nubushobozi bwicyuma.Kubwibyo, ifite akamaro gakomeye mubirere byindege za gisirikari no mubindi birindiro byigihugu ndetse nimirima yihariye, cyane cyane iyo anode ari tantalum pentoxide na cathode ihumeka dioxyde de Hybrid supercapacitor igizwe na rutheniyumu yiganje murwego rwo kurinda igihugu kubera ibiranga ibisubizo byinshyi kandi ubushyuhe bwo hejuru kandi buke. | ||
| Gutanga Ubushobozi | Ruthenium (IV) oxyde hydrat CAS NO.32740-79-7 nigicuruzwa cyacu gikora buri gihe, waba ukeneye icyitegererezo gito cyangwa kinini, isosiyete yacu irashobora kugitanga kumugaragaro. | ||
| Kumenyesha amakuru | |
| Niba ushimishijwe na hydratide ya Ruthenium (IV) CAS NO.32740-79-7, umva utubwire nyamuneka, kandi tuzaguha ibicuruzwa byiza, igiciro cyiza na serivisi nziza, dutegereje ubufatanye. | |
| E-imeri | |
| Terefone No. | +86 139 6251 3054 +86 136 2174 3828 |
Ibicuruzwa byashyizwe ku rutonde nisosiyete birimo patenti, bigenewe ubushakashatsi niterambere gusa ntabwo bigurishwa;ibicuruzwa bigenzurwa bizagurishwa hubahirijwe cyane amategeko y’Ubushinwa n’amategeko y’igihugu aho bigurwa, kandi ibicuruzwa byose ntibikwiriye gukoreshwa n'abantu.Nibigurishwa, bizaba bigize igihugu kibangamiye ipatanti, ingaruka zose zijyanye nazo zizagurwa nuwaguze.
![(S) - [2,2′-Bis (diphenylphosphino) -1,1′-binaphthyl] dichlororuthenium CAS NO.134524-84-8](http://cdn.globalso.com/shlzpharma/134524-84-8-2.png)
